Lv37
298 积分 2023-08-20 加入
Cancer immunoediting: from immunosurveillance to tumor escape
25天前
已完结
Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation
25天前
已完结
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
26天前
已完结
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
26天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
26天前
已完结
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update
26天前
已完结
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
26天前
已完结
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer
1个月前
已完结
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
1个月前
已完结
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?
1个月前
已完结
皖公网安备34019202002308
